Pfizer Makes Efforts To Intervene In Lawsuit Involving FDA’s Release Of Covid Vaccine Data, Reuters Reveals

Pfizer Makes Efforts To Intervene In Lawsuit Involving FDA’s Release Of Covid Vaccine Data, Reuters Reveals

The giant pharmaceuticals company, Pfizer, continues to shine in the spotlight these days. The other day, we were revealing that Daily Mail noted the fact that Pfizer and its partner, BioNTech, have officially submitted data to the U.S. Food and Drug Administration (FDA) to have its vaccine authorized for use in children aged six months to four years old.

The company has just revealed the planned move, following reports earlier in the day that the regulatory agency was urging them to submit an application soon.

Here’s their title below:

As we already noted the other day, they also claim that some doubt the shot is needed for people that young due to the little risk they face from the virus.

“Ultimately, we believe that three doses of the vaccine will be needed for children 6 months through 4 years of age to achieve high levels of protection against current and potential future variants.”

This is what Pfizer CEO Albert Bourla said. He continued and revealed:

‘If two doses are authorized, parents will have the opportunity to begin a COVID-19 vaccination series for their children while awaiting potential authorization of a third dose.”

Pfizer makes efforts to intervene in an important lawsuit 

Now, the important press agency Reuters notes the following:

“Pfizer Inc wants to intervene in a Texas federal lawsuit seeking information from the U.S. Food and Drug Administration used in licensing the company’s COVID-19 vaccine, a litigation move that plaintiffs who are suing for the data say is premature.”

It’s been reported that Pfizer’s lawyers at DLA Piper told U.S. District Judge Mark Pittman on Jan. 21 it wanted a role in the proceedings to help the FDA avoid “inappropriately” disclosing trade secret and confidential commercial information.

More publications are picking up on the news and revealing that the FDA is asking the court to delay the first 55,000 page production until May. 

You can check out the official documents in order to see all the necessary details requiring FDA to reveal the info. Meanwhile, pharma startups can check for OTC and Rx drug manufacturing licensing requirements per state to avoid financial and administrative penalties.

Pfizer scandal involving covid vaccines 

There is a new scientific study that has been published last month in Research Gate which shows mind-blowing covid vaccine potential results.

Of course, this will turn out to be surrounded by tons of controversies, just like any other subject involving the covid vaccines and especially their potential side effects. 

In the study’s abstract, the authors address the mRNA covid 19 vaccines and possible results.

“both experimental and observational evidence reveals a very different immune response to the vaccines compared to the response to infection with SARS-CoV-2. As we will show, the genetic modifications introduced by the vaccine are likely the source of these differential responses. In this paper, we present the evidence that vaccination, unlike natural infection, induces a profound impairment in type I interferon signaling, which has diverse adverse consequences to human health.”

Make sure to check out some other interesting data about the effectiveness of covid-imposed lockdowns and more. 

Rada Mateescu

Passionate about freedom, truth, humanity, and subjects from the science and health-related areas, Rada has been blogging for about ten years, and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.